Home LiteratureArticle Details
PMID: 19401677 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Predicting and controlling the reactivity of immune cell populations against cancer.

Molecular systems biology ·Vol. 5 ·2009-00-00 ·Pages 265

Oved K, Eden E, Akerman M, Noy R, Wolchinsky R, Izhaki O, Schallmach E, Kubi A, Zabari N, Schachter J, Alon U, Mandel-Gutfreund Y, Besser MJ, Reiter Y

Abstract

Heterogeneous cell populations form an interconnected network that determine their collective output. One example of such a heterogeneous immune population is tumor-infiltrating lymphocytes (TILs), whose output can be measured in terms of its reactivity against tumors. While the degree of reactivity varies considerably between different TILs, ranging from null to a potent response, the underlying network that governs the reactivity is poorly understood. Here, we asked whether one can predict and even control this reactivity. To address this we measured the subpopulation compositions of 91 TILs surgically removed from 27 metastatic melanoma patients. Despite the large number of subpopulations compositions, we were able to computationally extract a simple set of subpopulation-based rules that accurately predict the degree of reactivity. This raised the conjecture of whether one could control reactivity of TILs by manipulating their subpopulation composition. Remarkably, by rationally enriching and depleting selected subsets of subpopulations, we were able to restore anti-tumor reactivity to nonreactive TILs. Altogether, this work describes a general framework for predicting and controlling the output of a cell mixture.

MeSH Terms
Cell Separation Humans Lymphocyte Subsets/immunology Lymphocytes, Tumor-Infiltrating/immunology Models, Immunological Neoplasms/immunology
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Oved Kfir
Department of Biology, Technion Israel Institute of Technology, Haifa, Israel.
Eden Eran
Akerman Martin
Noy Roy
Wolchinsky Ron
Izhaki Orit
Schallmach Ester
Kubi Adva
Zabari Naama
Schachter Jacob
Alon Uri
Mandel-Gutfreund Yael
Besser Michal J
Reiter Yoram
References (26)
26 references, click to expand
  1. A module map showing conditional activity of expression modules in cancer.
    Nat Genet. 2004 Oct;36(10):1090-8 PMID: 15448693
  2. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis.
    Br J Cancer. 2004 Nov 1;91(9):1711-7 PMID: 15494715
  3. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
    N Engl J Med. 2003 Jan 16;348(3):203-13 PMID: 12529460
  4. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes.
    Eur J Immunol. 1977 Nov;7(11):353-7 PMID: 304003
  5. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.
    J Immunother. 2003 Jul-Aug;26(4):332-42 PMID: 12843795
  6. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
    J Exp Med. 2005 Apr 18;201(8):1257-68 PMID: 15824085
  7. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Nature. 2006 Mar 23;440(7083):540-4 PMID: 16525420
  8. Expression of CD33 antigen on normal human activated T lymphocytes.
    Blood. 1994 Mar 1;83(5):1442-3 PMID: 8118046
  9. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.
    Nat Med. 1999 Jun;5(6):677-85 PMID: 10371507
  10. Effector memory T cells, early metastasis, and survival in colorectal cancer.
    N Engl J Med. 2005 Dec 22;353(25):2654-66 PMID: 16371631
  11. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
    Science. 1999 Oct 15;286(5439):531-7 PMID: 10521349
  12. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
    J Immunol. 1993 Apr 15;150(8 Pt 1):3161-9 PMID: 7682233
  13. Gene expression profiling predicts clinical outcome of breast cancer.
    Nature. 2002 Jan 31;415(6871):530-6 PMID: 11823860
  14. Differential down-regulation of CD28 by B7-1 and B7-2 engagement.
    Transplantation. 1997 Nov 27;64(10):1497-9 PMID: 9392322
  15. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.
    J Immunol. 1994 Sep 15;153(6):2807-18 PMID: 8077684
  16. A plaidoyer for 'systems immunology'.
    Immunol Rev. 2006 Apr;210:229-34 PMID: 16623774
  17. What is a support vector machine?
    Nat Biotechnol. 2006 Dec;24(12):1565-7 PMID: 17160063
  18. The immune-body cytokine network defines a social architecture of cell interactions.
    Biol Direct. 2006 Oct 24;1:32 PMID: 17062134
  19. Paradoxical roles of the immune system during cancer development.
    Nat Rev Cancer. 2006 Jan;6(1):24-37 PMID: 16397525
  20. T-cell regulation by CD28 and CTLA-4.
    Nat Rev Immunol. 2001 Dec;1(3):220-8 PMID: 11905831
  21. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
    J Exp Med. 1998 Nov 2;188(9):1641-50 PMID: 9802976
  22. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.
    PLoS Med. 2005 Sep;2(9):e284 PMID: 16124834
  23. Size and connectivity as emergent properties of a developing immune network.
    J Theor Biol. 1991 Apr 7;149(3):381-424 PMID: 2062103
  24. Immunoregulatory T cells in tumor immunity.
    Curr Opin Immunol. 2004 Apr;16(2):157-62 PMID: 15023407
  25. The regulation of lymphocyte activation by inhibitory receptors.
    Curr Opin Immunol. 2004 Jun;16(3):328-36 PMID: 15134782
  26. Seventeen-colour flow cytometry: unravelling the immune system.
    Nat Rev Immunol. 2004 Aug;4(8):648-55 PMID: 15286731
Article Info
Journal
Molecular systems biology
Abbr.
Mol Syst Biol
ISSN
1744-4292
Published
2009-00-00
Epub
2009-00-28
Pages
265
Language
English
Region
England
NLM ID
101235389
PMCID
PMC2683719
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com